Sirius Therapeutics Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Sirius Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of SRSD384 in Overweight or Obese Participants (NCT07557355) | Sirius Therapeutics Co., Ltd. | 2026-06-01 |
| A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA (NCT07140523) | Sirius Therapeutics Co., Ltd. | 2025-09-16 |
| A Study of SRSD216 in Patients With Elevated Lipoprotein (a) (NCT07172646) | Sirius Therapeutics Co., Ltd. | 2025-04-07 |
| A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease (NCT07318155) | Sirius Therapeutics Co., Ltd. | 2025-03-11 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects (NCT07655427) | Sirius Therapeutics Co., Ltd. | 2024-03-29 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants (NCT06116617) | Sirius Therapeutics Co., Ltd. | 2024-01-23 |
Track Sirius Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.